Quick Answer
Processa Pharmaceuticals, Inc. reported Total Revenue of $5.0 thousand for fiscal year 2016.
Processa Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2016 | $5.0K | -95.6% |
| 2015 | $113.4K | +5.8% |
| 2014 | $107.2K | -65.7% |
| 2013 | $312.5K | +62.6% |
| 2012 | $192.1K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| March 31, 2016 | $5.0K | -86.8% | -91.4% |
| September 30, 2015 | $58.2K | +10.5% | +190.2% |
| June 30, 2015 | $20.0K | -82.2% | -46.9% |
| March 31, 2015 | $37.8K | +84.8% | -28.2% |
| September 30, 2014 | $52.6K | -58.2% | -53.4% |
| June 30, 2014 | $112.8K | +16.0% | +452.2% |
| March 31, 2014 | $20.4K | +6.4% | -83.8% |
| September 30, 2013 | $125.9K | +156.7% | +29.4% |
- Processa Pharmaceuticals, Inc. showed a decrease of -95.6% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2016 period, Processa Pharmaceuticals, Inc.’s total revenue has declined by 97.4% (from $192.1 thousand to $5.0 thousand).
- The most recent figure is from Processa Pharmaceuticals, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on September 25, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: